ADHD Drugs and Cardiovascular Risk

Phenylpropanolamine and the Risk of Hemorrhagic Stroke

Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T. G., Feldmann, E. G., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432501 · Cited by 746

Contraindicated Use of Cisapride

Smalley, W. E., Shatin, D., Wysowski, D. K., Gurwitz, J. H., Andrade, S. E., Goodman, M. J., Chan, K. A., Platt, R. G., Schech, S. D., & Ray, W. A. (2000) · JAMA · doi:10.1001/jama.284.23.3036 · Cited by 253

Blood Pressure Changes Associated With Medication Treatment of Adults With Attention-Deficit/Hyperactivity Disorder

Wilens, T. E., Hammerness, P. G., Biederman, J., Kwon, A., Spencer, T. J., Clark, S., Scott, M., Podolski, A., Ditterline, J., Morris, M. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0215 · Cited by 149

Postmarketing Surveillance of Suicidal Adverse Events with Pediatric Use of Antidepressants

Mosholder, A. D., & Pamer, C. A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.33 · Cited by 25

Report From the Cardiovascular and Renal Drugs Advisory Committee

Nissen, S. E. (2005) · Circulation · doi:10.1161/circulationaha.105.573105 · Cited by 20

The Relative Safety of Ephedra Compared with Other Herbal Products

Kingston, R. L., & Borron, S. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00017 · Cited by 6

Prime Drug Interplay in Dental Practice

Mohan, S. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/16912.7434 · Cited by 7

Family structure and the gender gap in ADHD

Bedard, K., & Witman, A. E. (2019) · Review of Economics of the Household · doi:10.1007/s11150-019-09476-9 · Cited by 7

Kardiovaskulær risikovurdering ved bruk av AD/HD-medikamenter hos barn

Berg, A., Bråtane, E., Odland, H. H., Brudvik, C. E., Rosland, B., & Hirth, A. (2014) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.13.0565 · Cited by 8

Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides

Chen, C., Bussing, R., Hartzema, A. G., Shuster, J. J., Segal, R., & Winterstein, A. G. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3894 · Cited by 7

How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease?

Larsson, H. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2279608 · Cited by 7

Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?

Alan, J., Sanfilippo, F. M., Preen, D. B., & Bulsara, M. K. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00139.x · Cited by 6

Use of ADHD drugs in children and young adults does not increase risk of serious cardiovascular adverse events compared with non-use

Winterstein, A. G. (2012) · Evidence-Based Mental Health · doi:10.1136/ebmental-2011-100514 · Cited by 6

Long-term Safety of Stimulant Medications Used to Treat Children with ADHD

Lerner, M., & Wigal, T. L. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080101-10 · Cited by 6

ADHD medications and cardiovascular adverse events in children and adolescents: cross‐national comparison of risk communication in drug labeling

Sieluk, J., Palasik, B. N., dosReis, S., & Doshi, P. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4164 · Cited by 6

Defects Committee and the Council on Cardiovascular Nursing Association Council on Cardiovascular Disease in the Young Congenital Cardiac Receiving Stimulant Drugs: A Scientific Statement From the American Heart Cardiovascular Monitoring of Children and Adolescents With Heart Disease

Uzark, K. C., Webb, C. L., Vetter, V. L., Elia, J., Erickson, C., Berger, S., & Blum, N. J. (2008) · Cited by 6

Attention‐Deficit Hyperactivity Disorder

Rube, D. M., & Kaur, T. (2012) · Wiley eBooks · doi:10.1002/9781119962229.ch10 · Cited by 6

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Fairman, K. A., Davis, L. E., Peckham, A. M., & Sclar, D. A. (2018) · Drugs - Real World Outcomes · doi:10.1007/s40801-017-0129-2 · Cited by 5

Pharmacologic Management of Excessive Daytime Sleepiness

Ono, T., Takenoshita, S., & Nishino, S. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.06.012 · Cited by 5

Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie Bundesarbeitsgemeinschaft Leitender Klinikärzte für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie Berufsverband der Ärzte für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie Stellungnahme zu fraglichen kardialen Risiken der Stimulanziengabe

Fegert, J. M., Hebebrand, J., & Fachgesellschaften, K. E. D. D. (2006) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.34.4.295 · Cited by 5

Preface

Greydanus, D. E., Patel, D. R., & Feucht, C. L. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.11.005 · Cited by 5

Attention‐Deficit/Hyperactivity Disorder Medication Use in Pregnancy and Risk of Preterm Birth: A Population‐Based Cohort Study

Srinivas, C., Karlstad, Ø., Stigum, H., Furu, K., Cesta, C. E., Reutfors, J., Hutcheon, J. A., & Cohen, J. M. (2025) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.70031 · Cited by 5

Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment

Nahshoni, E., Golubchik, P., Glazer, J., Sever, J. M., Strasberg, B., Imbar, S., Shoval, G., Weizman, A., & Zalsman, G. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0233-x · Cited by 4

Pharmacological Cognitive Enhancement: Examining the Ethical Principles Guiding College Students’ Abstention

Bavarian, N., Sumstine, S., Mendez, J., Yomogida, K., Figueroa, W., & Lam, C. (2018) · Neuroethics · doi:10.1007/s12152-018-9389-0 · Cited by 4

Psychopharmaka

Lohse, M. J., Lorenzen, A., & Müller-Oerlinghausen, B. (2007) · Springer eBooks · doi:10.1007/978-3-540-34370-7_42 · Cited by 4

Safety of non‐therapeutic atomoxetine exposures—a national poison data system study

Monte, A. A., Ceschi, A., & Bodmer, M. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2334 · Cited by 4

Time Spent With Children and Working Parents’ Willingness to Medicate ADHD-Like Behaviors

Pajo, B., & Cohen, D. (2013) · SAGE Open · doi:10.1177/2158244013512134 · Cited by 3

Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death

Besag, F. (2009) · Drug Safety · doi:10.2165/11530340-000000000-00000 · Cited by 4

Maintenance of Wakefulness With Lisdexamfetamine Dimesylate, Compared With Placebo and Armodafinil in Healthy Adult Males Undergoing Acute Sleep Loss

Gasior, M., Freeman, J., Zammit, G. K., Donnelly, P., Gao, J., Ferreira‐Cornwell, M. C., & Roth, T. G. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000202 · Cited by 4

Pharmacologic treatment of cognitive impairment aftertraumatic brain injury

Whyte, J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9781316529898.023 · Cited by 4

Psychopharmaka

Lohse, M. J., & Müller-Oerlinghausen, B. (2008) · Springer eBooks · doi:10.1007/978-3-540-69219-5_39 · Cited by 4

Facts and Public Policy

Shader, R. I., & Oesterheld, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000225814.94.999.7d · Cited by 4

Do Stimulants Prevent Substance Use and Misuse Among Youth With Attention-Deficit/Hyperactivity Disorder? The Answer Is Still Maybe

Goldstein, B. I. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.016 · Cited by 4

Normality and abnormality

Baxter, P. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206001885 · Cited by 4

Surdiagnostic du TDAH au Québec: Impact de l’âge d’entrée à l’école, différences régionales et coûts sociaux et économiques

Haeck, C., Lefebvre, G., Lefèbvre, P., & Merrigan, P. (2023) · doi:10.54932/dtdb7162 · Cited by 4

Cardiovascular Implications of the Enhanced Games: Performance Enhancing Drugs in Competition and Recreation

Vecchiato, M., Palermi, S., Zámodics, M., Babity, M., Eftekhari, M., Ryali, R., Luk, J., Taseh, A., Ashkani‐Esfahani, S., Merkely, G., et al. (2026) · Sports Medicine - Open · doi:10.1186/s40798-026-01026-9 · Cited by 3

An unusual case of commotio cordis resulting in ventricular flutter

Davey, B., Quintana, C., & Upadhyay, S. (2018) · Journal of Emergencies Trauma and Shock · doi:10.4103/jets.jets_78_17 · Cited by 3

Ablation of supraventricular tachycardia allows more liberal therapy in some children with attention‐deficit–hyperactivity disorder

Shetty, I., Silver, E. S., Hordof, A. J., Goldberg, P. H., & Liberman, L. (2011) · Pediatrics International · doi:10.1111/j.1442-200x.2011.03326.x · Cited by 3

Attention‐Deficit Hyperactivity Disorder and Long‐QT Syndrome: Risky Business

Kaltman, J. R., & Berul, C. I. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12744 · Cited by 3

The Use of Prescription Drugs for Academic Performance Enhancement in College Aged Students

Sweeney, S. (2010) · Providence College Digital Commons (Providence College) · Cited by 3

A case of ST elevation myocardial infarction precipitated by methylphenidate therapy for gait freeze

Connell, C., Gellatly, R. M., Dooley, M. J., & Shaw, J. A. (2015) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1077 · Cited by 3

Anxiety and depression: leading edge of therapy

Mathew, S. J., & Charney, D. S. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20049 · Cited by 3

Drug Abuse in Cardiovascular Diseases

Furlanello, F., Serdoz, L. V., AMBROGGI, L. D., & Cappato, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_32 · Cited by 3

Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications.

Guertin, J. R., LeLorier, J., Durand, M., Gow, R. M., Holbrook, A. M., & Levine, M. (2014) · PubMed · Cited by 3

It is likely that the risk of cardiovascular events from pharmaceuticals as COX-2 inhibitors can be reduced significantly by standard pharmaceutical and lifestyle preventative measures

Hellstrom, H. R. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.05.027 · Cited by 3

The Association Between Stimulant Medication Use and Mortality

Morrow, J., Moreton, U., Xu, T., Tatonetti, N. P., Wang, Y., & Walsh, B. T. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002066 · Cited by 2

The impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families

Cheng, A., Tithecott, G., Edwards, W. E., & Johnston, I. G. (2007) · Paediatrics & Child Health · doi:10.1093/pch/12.5.373 · Cited by 2

The Risks Associated With Stimulant Medication Use in Child and Adolescent Populations Diagnosed With Attention-Deficit/Hyperactivity Disorder

Stolzer, J. M. (2012) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.14.1.5 · Cited by 2

Kardiovaskuläres Risiko bei ADHS-Behandlung

Wenzel‐Seifert, K., & Haen, E. (2012) · NeuroTransmitter · doi:10.1007/s15016-012-0369-z · Cited by 2

Características das prescrições de metilfenidato em ambulatório de neuropediatria

de Lima, C. H., Paiola, G. C., Maier, A. M. R. R., Garcia, L. F., & Massuda, E. M. (2022) · Saúde em Debate · doi:10.1590/0103-11042022e515 · Cited by 3

Ad/Hd: Possible Diagnosis And Treatment

Reichelt, K. L., Nødland, M., Fosse, K., & Marie, K. A. (2015) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.28615 · Cited by 2

Adverse Events in the Manipulation of Pediatric Patients: Flaws in a Systematic Review

Rosner, A. L. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0124 · Cited by 2

Protopathic stimulant use among children with symptoms of ADHD

Barnard-Brak, L. M., To, Y. M., & Fearon, D. D. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0055-1 · Cited by 2

Assessment of Cardiovascular Risks due to Methylphenidate in Six Months of Treatment in Children with Attention Deficit and Hyperactivity Disorder

Arı, M. E., Çetin, İ. İ., Ekici, F., Kocabaş, A., Eminoğlu, S., Güney, E., Ozturk, O., Dinç, G. Ş., & Göker, Z. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140702010106 · Cited by 2

Adverse Drug Reactions and Drug-drug Interactions

Benton, W. W., Brothers, A. W., Kirk, C. J., Irby, G. A. L., & Rubino, C. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10118-1 · Cited by 2

Stimulant Use Disorders and Related Emergencies

Green, A. S. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_3 · Cited by 2

Impacto del tratamiento con metilfenidato sobre las propiedades funcionales y estructurales del ventrículo izquierdo a medio plazo en el trastorno por déficit de atención e hiperactividad

Ron, A. G., Mesa, M. R., Vivas, E. A., & Gascón, M. B. (2021) · Anales de Pediatría · doi:10.1016/j.anpedi.2020.12.014 · Cited by 2

Cardiovascular Toxicity of Noncardiovascular Drugs

Bajracharya, O., Shankar, P. R., & Jha, N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416595-3.00010-4 · Cited by 2

Stimulants and Sudden Death: What Is the Real Risk?

Furman, L. (2007) · PEDIATRICS · doi:10.1542/peds.2006-3029 · Cited by 2

A Proposed Longitudinal Study of Boys' and Men's Health and Well-being in Greater Sydney, Australia

Monaem, A., Macdonald, J., Woods, M., Hughes, R., Orchard, M., & Jasprizza, E. (2008) · International Journal of Men s Health · doi:10.3149/jmh.0702.192 · Cited by 2

Kontrolluntersuchungen unter Therapie mit Psychopharmaka

Stuppäck, C., Geretsegger, C., & Egger, C. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_12 · Cited by 2

Toxins and the heart

Lau, R. P., & Fishbein, M. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00012-8 · Cited by 1

Young patients with congenital heart disease on psychotropic medications have higher recurrence of cardiac events than those without CHD

Elmowafi, H., Sollander, S. E., Risberg, E., & Naumburg, E. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1771808 · Cited by 1

Behandlung mit Methylphenidat im Kindesalter

Fegert, J. M., Bode, H., Hach, I., Hargarter, L., & Müller, W. E. (2007) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-007-1573-y · Cited by 1

The use of aripiprazole as an alternative medication to methylphenidate for treatment of attention-deficit/hyperactivity disorder

Chaichan, W., & Kittipeerachon, M. (2010) · Journal of Mental Health of Thailand - วารสารสุขภาพจิต แห่งประเทศไทย · doi:10.14456/dmhjournal.2010.18 · Cited by 1

Uso de metilfenidato en niños y adolescentes usuarios de servicios de asistencia pública de Montevideo

Speranza, N., Goyeneche, N., Ferreiro, D., Olmos, I., Bauger, M., Oyarzun, M., Aramendi, I., Greckzanic, A., & Giachetto, G. (2008) · Americanae (AECID Library) · Cited by 1

La desatención y la hiperactividad en los niños como modo de manifestar el sufrimiento psíquico

Janin, B. (2013) · Psicología Conocimiento y Sociedad · Cited by 1

Treatment Effectiveness of an Adolescent Residential Treatment Center for Males Using a Psychotropic Medication Reduction Protocol

Dodge, S. (2009) · CommonKnowledge Research Repository (Pacific University Oregon) · Cited by 1

Toxins and the Heart

Fishbein, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420219-1.00017-3 · Cited by 1

Stimulant Pharmacotherapy for Adults with ADHD

Hammerness, P. G. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_5 · Cited by 1

Peculiaridades del Consentimiento Informado en Salud Mental. Considerando el Caso TDA/H como Ejemplo

Eizaguirre, M. Á. V., & Aróstegui, J. A. I. (2014) · Clínica Contemporánea · doi:10.5093/cc2014a9 · Cited by 1

Psychoactive Drugs in Plastic Surgery

Davison, S. P., Baglien, B. D., & Hayes, K. D. (2017) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000001282 · Cited by 1

Treatment with methylphenidate in childhood and adolescence. Conclusions reached at an expert consensus conference

Fegert, J. M., Bode, H., Hach, I., Hargarter, L., & Mueller, W. E. (2007) · Monatsschrift Kinderheilkunde · Cited by 1

The impact of methylphenidate treatment on the functional and structural properties of the left ventricle: A medium-term prospective study

Ron, A. G., Mesa, M. R., Vivas, E. A., & Gascón, M. B. (2021) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2020.12.017 · Cited by 1

Update on drugs for hyperactivity in childhood

(2007) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2007.45537 · Cited by 1

Tratamiento del trastorno por déficit de atención con o sin hiperactividad en Atención Primaria: tratamiento farmacológico con metilfenidato y opciones no farmacológicas

Etxebarria, X. T., & Pérez, M. F. (2006) · Hispana · Cited by 1

Risk of cardiovascular disease associated with ADHD treatment

Holt, A., Lamberts, M., Elberling, H., & Hansen, H. G. (2025) · Ugeskrift for Læger · doi:10.61409/v11240840 · Cited by 1

People with long QT syndrome who have attention deficit hyperactivity disorder deserve to be treated properly

Skinner, J. R., & Muir, C. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.015 · Cited by 1

Stimulant pharmacotherapy for adults with attention deficit hyperactivity disorder: cardiovascular effects and risk of sudden cardiac death

Pucci, M. (2016) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000019 · Cited by 1

The frequency and patterns of psychotropic use among children and adolescents in an outpatient psychiatric facility: An observational study

Bhat, B. A., Hussain, A., Qadir, W., & Dar, S. (2019) · Muller Journal of Medical Sciences and Research · doi:10.4103/mjmsr.mjmsr_13_19 · Cited by 1

Methylphenidate Treatment Initiated During Childhood Is Continued in Adulthood in Half of the Study Population

Cheung, K., Verhamme, K. M. C., Herings, R. M. C., Visser, L. E., & Stricker, B. H. C. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0170 · Cited by 1

Intervention, Treatment, and Management of ADHD

Vloet, T. D., von Polier, G. G., & Herpertz‐Dahlmann, B. (2020) · doi:10.1002/9781119159322.ch33 · Cited by 1

EL ADHD Y LOS DIAGNÓSTICOS EN LA INFANCIA: LA COMPLEJIDAD DE LAS DETERMINACIONES

Janin, B. (2007) · Repositorio Institucional UCES (Texas A&M University Libraries) · Cited by 1

A Profile of Youth and Divorce: Considerations for Parents and Educators Concerning Emotional and Behavioural Fragility and Resiliency

Buttinger, P. (2012) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1

Treatment of Childhood Hypertension

Batisky, D. L., Robinson, R. F., & Mahan, J. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04883-5.50050-7 · Cited by 1

Attention‐ D eficit/Hyperactivity Disorder

Acosta, M. T., Arcos‐Burgos, M., & Muenke, M. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb002053 · Cited by 1

Psychopharmaka

Lohse, M. J., Lorenzen, A., & Müller-Oerlinghausen, B. (2008) · Springer eBooks · doi:10.1007/978-3-540-72548-0_42 · Cited by 1

Cardiovascular Issues and the QT Interval

Suys, B. E., & Dekie, L. (2013) · Wiley eBooks · doi:10.1002/9781118312087.ch31

Genetic and Environmental Factors in Attention‐Deficit Hyperactivity Disorder

Baker, A. A., Taylor, M., & Richardson, J. R. (2010) · Wiley eBooks · doi:10.1002/9780470917060.ch14

The origins and consequences of attention deficit hyperactivity disorder

Chang, Z. (2013) · Figshare

What's New with Stimulants?

Purushothaman, P. (2013) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2013.18.4.1

A 2009 update on adult ADHD

Surman, C. B. H., Hammerness, P. G., & Miller, K. (2009) · Current Attention Disorders Reports · doi:10.1007/s12618-009-0018-z

Regarding cancer-related fatigue

Revannasiddaiah, S., & Rastogi, M. (2012) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302012000200002

INCREASED VIGILANCE URGED ON RISK OF PSYCHOSIS WITH ADHD DRUGS

Hurley, D. (2006) · Neurology Today · doi:10.1097/00132985-200605020-00015

Methylphenidate and Psychotic Depression

Ng, B. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181911a9c

Some New Developments in Psychiatry

Roos, L. (2007) · South African Family Practice · doi:10.1080/20786204.2007.10873570

EEG neurofeedback for inattention in children with Attention Deficit Hyperactivity Disorder (ADHD)

Clarke, C., Bannon, F. J., & Skokauskas, N. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009207.pub2

Basics of prescribing psychopharmacologic agents

Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544705.006

Rights and Great Responsibilities of Academic Pediatricians

Cooper, W. O. (2013) · Academic Pediatrics · doi:10.1016/j.acap.2013.07.006

¿Suspender o no el tratamiento? ¿Durante cuánto tiempo debe mantenerse el tratamiento farmacológico del trastorno por déficit de atención/hiperactividad?

van de Loo-Neus, G. H. H., Rommelse, N. N. J., & Buitelaar, J. K. (2011) · Psiquiatría Biológica · doi:10.1016/j.psiq.2011.10.008

Hemorragia de núcleo caudado por anestesia dental

Fernández, J. G., Morales, V. G., & Trejo-Gabriel-Galan, J. M. (2010) · Neurología · doi:10.1016/j.nrl.2010.07.008

Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy

Generali, J. A. (2006) · Hospital Pharmacy · doi:10.1310/hpj4105-484

Does 20 mg long-acting methylphenidate alter blood pressure and heart rate in children with ADHD?

Wiguna, T., Wibisono, S., Sastroasmoro, S., & Suyatna, F. D. (2011) · Paediatrica Indonesiana · doi:10.14238/pi51.5.2011.282-7

New management issues for commonly occurring psychiatric syndromes are discussed in this editorial.

Roos, L. (2007)

Adverse Effects of Psychostimulant Medications Working Group

Cooper, W. O., Habel, L. A., Chan, K. A., & Mosholder, A. D. (2011)

Depresif Bozukluklarin Tedavisinde Psikostimulanlar in the Treatment of Depressive Disorders

Ekinci, O., & Bolek, S. (2015)

FDA panel recommends black box warning on ADHD stimulant medications

Gorman, R. L. (2006) · AAP News · doi:10.1542/27.4.16 · Cited by 4

FDA ponders cardiovascular risks of ADHD drugs

Young, D. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/news050058 · Cited by 2

ADHD drugs should carry warning, FDA committee recommends

Tanne, J. H. (2006) · BMJ · doi:10.1136/bmj.332.7544.748-c · Cited by 1

FDA Panel Wants Warnings On ADHD Medications

Rosack, J. (2006) · Psychiatric News · doi:10.1176/pn.41.5.0001 · Cited by 1

Perspective The NEW ENGLAND JOURNAL of MEDICINE

(2006)